Company / Revenue
Caris Life Sciences, Inc. Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$812.0M
FY2025
5-year range
$306.1M / $812.0M
FY2023-FY2025
Trend
+97.0%
vs FY2024
Sector context
#109 of 155
Health Care
What the data says
At $812M, Caris Life Sciences, Inc.'s revenue ranks #109 of 155 in the Health Care sector. Improved from $306M to $812M over the past 2 years.
Based on SEC 10-K filings.
$812M in FY2025.
Improved from $306M to $812M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 155 in Health CareTop 70% of 155This company $812.0M Sector average $19.1B
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 97.0% year-over-year.
- Ranks #109 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $812.0M | +97.0% |
| FY2024 | $412.3M | +34.7% |
| FY2023 | $306.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026